Gujarat Alkalies and Chemicals Limited strategy deck summary

Strategy deck of 24 Feb 2026, summarised by AI from the filing.

Gujarat Alkalies and Chemicals uploaded an updated Investors Presentation (Dec-2025) to its website for investors and shareholders.

Key takeaways

1. Filing Gujarat Alkalies and Chemicals uploaded an updated Investors Presentation to its website for investors and shareholders.
2. Presentation The updated presentation is titled Investor Presentation Dec-2025 and is hosted on the company's website.
3. Filing date The letter to the exchanges is dated 24th February, 2026.
4. Promoter The company is promoted by the Government of Gujarat.
5. Registered office The registered office and works are at P.O. Ranoli-391350, Dist. Vadodara, Gujarat.

Original filing on BSE

Gujarat Alkalies and Chemicals Limited Q1 FY27 results

As filed: Revenue ₹1,245 cr (+13% year on year), EBITDA ₹222 cr (+88% year on year), PAT ₹55.0 cr, EBITDA margin 17.8% (+713 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

• Q4 FY26: Revenue ₹1,125 cr (+5% year on year), EBITDA ₹110 cr (−4% year on year), PAT ₹15.0 cr (+66% year on year), EBITDA margin 9.8% (−84 bps). Score 25 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA growth was below it. EBITDA margin fell 84 bps year on year. Other income 221% of PBT. Tax rate 5%. Consolidated profit +66% but standalone -62%. Share price after the results: −9.3% in 27 days (Nifty 500: +0.6%).
• Q3 FY26: Revenue ₹1,044 cr (+2% year on year), EBITDA ₹105 cr (+8% year on year), PAT −₹20.0 cr, EBITDA margin 10.0% (+61 bps). Score 15 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA growth was below it. EBITDA margin rose 61 bps year on year. Other income 241% of PBT. Tax rate 188%. Revenue fell 4% from last quarter. Share price after the results: −4.4% in 28 days (Nifty 500: −4.1%).
• Q2 FY26: Revenue ₹1,083 cr (+9% year on year), EBITDA ₹74.0 cr (−1% year on year), PAT ₹16.0 cr, EBITDA margin 6.8% (−74 bps). Score 40 of 100, In line with trend. Revenue growth was above the company's own trend; EBITDA growth was below it. EBITDA margin fell 74 bps year on year. Other income 454% of PBT. Tax rate -23%. Share price after the results: −7.4% in 28 days (Nifty 500: +1.3%).
• Q1 FY26: Revenue ₹1,105 cr (+13% year on year), EBITDA ₹118 cr (+57% year on year), PAT −₹14.0 cr, EBITDA margin 10.7% (+300 bps). Score 45 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA growth was in line with it. EBITDA margin rose 300 bps year on year. Other income 80% of PBT. Profit fell 256% from last quarter. Share price after the results: +1.6% in 28 days (Nifty 500: +1.7%).
• Q4 FY25: Revenue ₹1,075 cr (+7% year on year), EBITDA ₹114 cr (+293% year on year), PAT ₹9.0 cr, EBITDA margin 10.6% (+771 bps). Score 60 of 100, In line with trend. Revenue growth was above the company's own trend; EBITDA growth was well above it. EBITDA margin rose 771 bps year on year. Other income 104% of PBT. Tax rate 4%. Share price after the results: −9.4% in 28 days (Nifty 500: +0.2%).
• Q3 FY25: Revenue ₹1,029 cr (+12% year on year), EBITDA ₹97.0 cr (+300% year on year), PAT −₹11.0 cr, EBITDA margin 9.4% (+867 bps). Score 45 of 100, In line with trend. Revenue and EBITDA growth were well above the company's own trend. EBITDA margin rose 867 bps year on year. Other income 375% of PBT. Tax rate -100%.
• Q2 FY25: Revenue ₹991 cr (+2% year on year), EBITDA ₹75.0 cr (+67% year on year), PAT −₹18.0 cr, EBITDA margin 7.6% (+293 bps). Score 15 of 100, Below trend. EBITDA margin rose 293 bps year on year. Other income 377% of PBT. Not enough history for a trend yet: scored on growth alone.

Past price moves after results do not indicate future moves. Not a recommendation.

Gujarat Alkalies and Chemicals Limited earnings call, investor presentation and press release summaries

• Q1 FY27: Results press release (23 Jul 2026)
• Other events: Investor presentation (8 Jul 2026), Strategy deck (24 Feb 2026), Investor presentation (28 Nov 2025), Investor presentation (4 Sep 2025), Investor presentation (6 Jun 2025)